These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 28639487)

  • 21. Concomitant nevirapine impacts pharmacokinetic exposure to the antimalarial artemether-lumefantrine in African children.
    Huang L; Carey V; Lindsey JC; Marzan F; Gingrich D; Graham B; Barlow-Mosha L; Ssemambo PK; Kamthunzi P; Nachman S; Parikh S; Aweeka FT;
    PLoS One; 2017; 12(10):e0186589. PubMed ID: 29065172
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Artemether-lumefantrine: an option for malaria.
    Stover KR; King ST; Robinson J
    Ann Pharmacother; 2012 Apr; 46(4):567-77. PubMed ID: 22496476
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Significant pharmacokinetic interactions between artemether/lumefantrine and efavirenz or nevirapine in HIV-infected Ugandan adults.
    Byakika-Kibwika P; Lamorde M; Mayito J; Nabukeera L; Namakula R; Mayanja-Kizza H; Katabira E; Ntale M; Pakker N; Ryan M; Hanpithakpong W; Tarning J; Lindegardh N; de Vries PJ; Khoo S; Back D; Merry C
    J Antimicrob Chemother; 2012 Sep; 67(9):2213-21. PubMed ID: 22687893
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The drug transporter ABCB1 c.3435C>T SNP influences artemether-lumefantrine treatment outcome.
    Kiaco K; Rodrigues AS; do Rosário V; Gil JP; Lopes D
    Malar J; 2017 Sep; 16(1):383. PubMed ID: 28934955
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Early clinical development of artemether-lumefantrine dispersible tablet: palatability of three flavours and bioavailability in healthy subjects.
    Abdulla S; Amuri B; Kabanywanyi AM; Ubben D; Reynolds C; Pascoe S; Fitoussi S; Yeh CM; Nuortti M; Séchaud R; Kaiser G; Lefèvre G
    Malar J; 2010 Sep; 9():253. PubMed ID: 20815879
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Malaria prevalence, severity and treatment outcome in relation to day 7 lumefantrine plasma concentration in pregnant women.
    Mutagonda RF; Kamuhabwa AA; Minzi OM; Massawe SN; Maganda BA; Aklillu E
    Malar J; 2016 May; 15(1):278. PubMed ID: 27177586
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical pharmacokinetics and pharmacodynamics and pharmacodynamics of artemether-lumefantrine.
    White NJ; van Vugt M; Ezzet F
    Clin Pharmacokinet; 1999 Aug; 37(2):105-25. PubMed ID: 10496300
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Coartem (artemether-lumefantrine) in Africa: the beginning of the end?
    Hastings IM; Ward SA
    J Infect Dis; 2005 Oct; 192(7):1303-4; author reply 1304-5. PubMed ID: 16136476
    [No Abstract]   [Full Text] [Related]  

  • 29. Population pharmacokinetics of mefloquine, piperaquine and artemether-lumefantrine in Cambodian and Tanzanian malaria patients.
    Staehli Hodel EM; Guidi M; Zanolari B; Mercier T; Duong S; Kabanywanyi AM; Ariey F; Buclin T; Beck HP; Decosterd LA; Olliaro P; Genton B; Csajka C
    Malar J; 2013 Jul; 12():235. PubMed ID: 23841950
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Supervised versus unsupervised intake of six-dose artemether-lumefantrine for treatment of acute, uncomplicated Plasmodium falciparum malaria in Mbarara, Uganda: a randomised trial.
    Piola P; Fogg C; Bajunirwe F; Biraro S; Grandesso F; Ruzagira E; Babigumira J; Kigozi I; Kiguli J; Kyomuhendo J; Ferradini L; Taylor W; Checchi F; Guthmann JP
    Lancet; 2005 Apr 23-29; 365(9469):1467-73. PubMed ID: 15850630
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Adding a single low-dose of primaquine (0.25 mg/kg) to artemether-lumefantrine did not compromise treatment outcome of uncomplicated Plasmodium falciparum malaria in Tanzania: a randomized, single-blinded clinical trial.
    Mwaiswelo R; Ngasala B; Jovel I; Aydin-Schmidt B; Gosling R; Premji Z; Mmbando B; Björkman A; Mårtensson A
    Malar J; 2016 Aug; 15(1):435. PubMed ID: 27565897
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Artesunate-amodiaquine versus artemether-lumefantrine for the treatment of acute uncomplicated malaria in Congolese children under 10 years old living in a suburban area: a randomized study.
    Ndounga M; Pembe Issamou Mayengue ; Casimiro PN; Koukouikila-Koussounda F; Bitemo M; Diassivy Matondo B; Ndounga Diakou LA; Basco LK; Ntoumi F
    Malar J; 2015 Oct; 14():423. PubMed ID: 26511848
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment of acute uncomplicated falciparum malaria with artemether-lumefantrine in nonimmune populations: a safety, efficacy, and pharmacokinetic study.
    Hatz C; Soto J; Nothdurft HD; Zoller T; Weitzel T; Loutan L; Bricaire F; Gay F; Burchard GD; Andriano K; Lefèvre G; De Palacios PI; Genton B
    Am J Trop Med Hyg; 2008 Feb; 78(2):241-7. PubMed ID: 18256423
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of bioavailability between the most available generic tablet formulation containing artemether and lumefantrine on the Tanzanian market and the innovator's product.
    Minzi OM; Marealle IA; Shekalaghe S; Juma O; Ngaimisi E; Chemba M; Rutaihwa M; Abdulla S; Sasi P
    Malar J; 2013 May; 12():174. PubMed ID: 23718725
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lumefantrine and Desbutyl-Lumefantrine Population Pharmacokinetic-Pharmacodynamic Relationships in Pregnant Women with Uncomplicated Plasmodium falciparum Malaria on the Thailand-Myanmar Border.
    Kloprogge F; McGready R; Hanpithakpong W; Blessborn D; Day NP; White NJ; Nosten F; Tarning J
    Antimicrob Agents Chemother; 2015 Oct; 59(10):6375-84. PubMed ID: 26239986
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparative evaluation of efficacy and safety of artesunate-lumefantrine vs. artemether-lumefantrine fixed-dose combination in the treatment of uncomplicated Plasmodium falciparum malaria.
    Pareek A; Chandurkar N; Srivastav V; Lakhani J; Karmakar PS; Basu S; Ray A; Pednekar S; Gupta PB; Suthar N; Lakhani S
    Trop Med Int Health; 2013 May; 18(5):578-87. PubMed ID: 23489465
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacokinetic interaction between etravirine or darunavir/ritonavir and artemether/lumefantrine in healthy volunteers: a two-panel, two-way, two-period, randomized trial.
    Kakuda TN; DeMasi R; van Delft Y; Mohammed P
    HIV Med; 2013 Aug; 14(7):421-9. PubMed ID: 23441978
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Adherence and efficacy of supervised versus non-supervised treatment with artemether/lumefantrine for the treatment of uncomplicated Plasmodium falciparum malaria in Bangladesh: a randomised controlled trial.
    Rahman MM; Dondorp AM; Day NP; Lindegardh N; Imwong M; Faiz MA; Bangali AM; Kamal AT; Karim J; Kaewkungwal J; Singhasivanon P
    Trans R Soc Trop Med Hyg; 2008 Sep; 102(9):861-7. PubMed ID: 18606428
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CYP2B6*6 Genotype Specific Differences in Artemether-Lumefantrine Disposition in Healthy Volunteers.
    Abdullahi ST; Soyinka JO; Olagunju A; Bolarinwa RA; Olarewaju OJ; Bakare-Odunola MT; Winterberg M; Tarning J; Owen A; Khoo S
    J Clin Pharmacol; 2020 Mar; 60(3):351-360. PubMed ID: 31549442
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Randomized comparison of amodiaquine plus sulfadoxine-pyrimethamine, artemether-lumefantrine, and dihydroartemisinin-piperaquine for the treatment of uncomplicated Plasmodium falciparum malaria in Burkina Faso.
    Zongo I; Dorsey G; Rouamba N; Dokomajilar C; Séré Y; Rosenthal PJ; Ouédraogo JB
    Clin Infect Dis; 2007 Dec; 45(11):1453-61. PubMed ID: 17990228
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.